Physician profile
Brian D Hess
NPI 1548540271
$2,793.13
in general payments reported to CMS, 2019-2025
22 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $410 · 2022: $559 · 2023: $229 · 2024: $1,294 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337 · Travel and Lodging: $443 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.56 |
| Travel and Lodging | $443.18 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,212.62 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Boston Scientific Corporation | $246.24 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Abbvie INC. | $214.03 | 2021-2024 | |
| Saluda Medical Americas, INC. | $163.72 | 2024-2025 | Evoke |
| Nevro Corp. | $152.28 | 2021-2022 | |
| Nalu Medical, INC. | $128.56 | 2021-2024 | Nalu Neurostimulation System |
| Lundbeck LLC | $108.96 | 2022-2025 | Vyepti |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Biodelivery Sciences International, INC. | $68.98 | 2021 | |
| Relievant Medsystems, INC. | $62.61 | 2021-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.44 | 2023 | Relistor |
| Stimwave Technologies Incorporated | $55.82 | 2021-2022 | |
| Averitas Pharma INC. | $47.03 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $43.93 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $34.40 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $30.60 | 2022 | |
| Allergan, INC. | $17.34 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.91 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $14.49 | 2025 | Dysport |
| Abbott Laboratories | $12.24 | 2021 | |
| Curonix LLC | $11.61 | 2022 | |
| Spr Therapeutics, INC | $6.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.